Medication info
Ecru Tablet 200 mg (Acyclovir)

Ecru Tablet 200 mg (Acyclovir)

Prescription medicationTablet
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
Kyung dong Pharm Co., Ltd.
Appearance
Light blue round tablets
Packaging
Domestic use: 30 tablets/bottle, 100 tablets/bottle, for export: 100 tablets (10 tablets/PTP x 10)
Approval status
Active

MFDS item code 198601102 · Notified 1986.09.08 · Insurance code 648101520

Summary

Main use
Treatment and prevention of herpes simplex; treatment of chickenpox and shingles
Who uses it
Adults · Children
Adult dosage
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir at a dose of 200 mg 5 times daily, at 4-hour intervals, for 5 days. Treatment may be extended in cases of severe initial infection. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection. In recurrent cases, treatment should preferably be started when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer this drug at a dose of 200 mg 4 times daily, at approximately 6-hour intervals. Alternatively, 400 mg may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg 2 ~ 3 times daily, after confirming its effectiveness. 3) To determine the natural course of the disease, patients receiving long-term treatment should periodically discontinue treatment every 6 ~ 12 months for assessment. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer this drug at a dose of 200 mg 4 times daily, at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer this drug at a dose of 800 mg 5 times daily, at approximately 4-hour intervals except during bedtime, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunocompromise or gastrointestinal malabsorption. 3) It is best to start treatment as soon as possible after infection; the earlier the treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience neuropsychiatric adverse reactions; caution should be exercised, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount accumulated following intravenous injection. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer this drug at a dose of 200 mg every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose of this drug to 800 mg twice daily, at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose of this drug to 800 mg 3 times daily, at approximately 8-hour intervals.
Children's dosage
○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in patients with impaired immune function 1) Age 2 years and older: Same as for adults. 2) Under 2 years: Administer 1/2 of the adult dose. 3) There are not yet sufficient data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg/kg body weight per dose (up to a maximum of 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours after the rash appears.

Ingredients

Manufacturer
Kyung dong Pharm Co., Ltd.

Efficacy & effects

Treatment and prevention of herpes simplex; treatment of chickenpox and shingles

  • Primary genital herpes
  • recurrent genital herpes
  • herpes simplex virus infections of skin and mucous tissues
  • shingles virus infections
  • acute pain
  • chickenpox
View approved original text

This medication is used to treat and prevent infections caused by the herpes simplex virus affecting the skin and mucous membranes, including primary and recurrent genital herpes. It is also effective in treating shingles virus infections, particularly for alleviating pain during the acute phase. However, its effectiveness for postherpetic neuralgia has not yet been firmly established. This medication is also used to treat chickenpox in children over 2 years of age. It works effectively against various viral infections and alleviates symptoms.

Dosage and Administration

Adult dosage

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir at a dose of 200 mg 5 times daily, at 4-hour intervals, for 5 days. Treatment may be extended in cases of severe initial infection. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection. In recurrent cases, treatment should preferably be started when prodromal symptoms or lesions first appear. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer this drug at a dose of 200 mg 4 times daily, at approximately 6-hour intervals. Alternatively, 400 mg may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg 2 ~ 3 times daily, after confirming its effectiveness. 3) To determine the natural course of the disease, patients receiving long-term treatment should periodically discontinue treatment every 6 ~ 12 months for assessment. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer this drug at a dose of 200 mg 4 times daily, at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose per administration may be increased to 400 mg, or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer this drug at a dose of 800 mg 5 times daily, at approximately 4-hour intervals except during bedtime, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunocompromise or gastrointestinal malabsorption. 3) It is best to start treatment as soon as possible after infection; the earlier the treatment is started, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience neuropsychiatric adverse reactions; caution should be exercised, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount accumulated following intravenous injection. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer this drug at a dose of 200 mg every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose of this drug to 800 mg twice daily, at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose of this drug to 800 mg 3 times daily, at approximately 8-hour intervals.

Children's dosage

○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in patients with impaired immune function 1) Age 2 years and older: Same as for adults. 2) Under 2 years: Administer 1/2 of the adult dose. 3) There are not yet sufficient data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg/kg body weight per dose (up to a maximum of 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours after the rash appears.

Precautions

This medication should not be used by patients who are allergic to it or its components. Caution is required when using this medication in patients with impaired kidney function, as mental adverse reactions may occur more readily. Patients with impaired liver function should also use this medication cautiously, as there is a risk of further deterioration in liver function. In infants and children, it should only be used minimally when absolutely necessary. Elderly patients are at higher risk for reduced kidney function, so caution should be exercised to prevent more pronounced side effects. Severe allergic reactions, such as anaphylactic shock, may occur, so if symptoms arise, the medication should be stopped immediately, and appropriate treatment should be sought. Skin reactions such as rashes, fever, blisters, and hives may occur, and use should be discontinued if these symptoms appear. Serious skin conditions such as Stevens-Johnson syndrome or toxic epidermal necrolysis may develop, so skin condition should be closely monitored. Mental symptoms such as confusion, hallucinations, seizures, drowsiness, anxiety, and insomnia may occur, particularly in elderly patients or those with diminished kidney function. This medication may affect kidney function, leading to renal failure or urinary abnormalities, so caution is necessary. Blood-related side effects may include leukopenia, anemia, and bleeding. Liver function abnormalities or symptoms of hepatitis and jaundice may occur, so liver status should be checked periodically. Gastrointestinal symptoms may include nausea, vomiting, abdominal pain, and diarrhea, and if these symptoms are severe, the medication should be discontinued. Generally, this medication is most effective when administered as soon as skin symptoms begin; for shingles, it is best to start treatment within 5 days, and for chickenpox, within 3 days. Adequate hydration is necessary during treatment, particularly when using high doses to prevent dehydration. Caution should be exercised during dangerous activities, such as driving or operating machinery, considering the possibility of altered consciousness. There may be interactions when used in conjunction with other medications, especially those affecting kidney function or specific drugs, so consultation with a specialist is advisable. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of using this medication, and it is safest to discontinue use while breastfeeding. In cases of overdose, severe neurological abnormalities and kidney damage may occur, so if overdose is suspected, immediate notification to medical personnel is necessary. Elderly patients or those with impaired kidney function should use the medication with adjusted dosage and intervals.

Side effects

  • Anaphylactic shock
  • anaphylactoid reaction
  • hypotension
  • dyspnea
  • chest tightness
  • photosensitivity reaction
  • fixed drug eruption
  • rash
  • fever
  • vesicles
Show 118 more
  • urticaria-like erythema
  • urticaria
  • alopecia
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • concentration difficulties
  • aggressive behavior
  • depersonalization
  • anxiety
  • ataxia
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • seizures
  • drowsiness
  • tremors
  • agitation
  • amnesia
  • insomnia
  • anxiety
  • talking to oneself
  • abnormal sensations
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • dizziness
  • renal failure
  • crystalluria
  • elevated BUN
  • elevated serum creatinine
  • hematuria
  • proteinuria
  • red blood cell casts in urine
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • hemorrhage
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • hepatic impairment
  • jaundice
  • abnormal liver function tests
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • soft stools
  • epigastric pain
  • stomach pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • malaise
  • generalized fatigue
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • hypertension
  • hypotension
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glycosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disorders
  • hair loss
  • sweating
  • hyponatremia
  • decreased serum protein
  • elevated total cholesterol
  • elevated triglycerides
  • elevated serum potassium
  • decreased serum albumin
  • anxiety
  • coma
  • seizures
  • drowsiness
  • confusion
  • hallucinations
  • agitation
  • epileptic seizures
  • comatose state

Not everyone experiences these, and they can vary from person to person.

Storage

This medication does not require special refrigeration and should be stored at room temperature. Avoid storing in excessively hot or humid places, and keep it in a cool area away from direct sunlight.

Appearance and packaging

Appearance

Light blue round tablets

Package unit

Domestic use: 30 tablets/bottle, 100 tablets/bottle, for export: 100 tablets (10 tablets/PTP x 10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.